Sinopharm says may be able to make over 1 bln vaccine doses in 2021

Credit: REUTERS/TINGSHU WANG

China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021, Chairman Liu Jingzhen said at a government press conference on Tuesday. (Reporting by Roxanne Liu and Tony Munroe, editing by Louise Heavens) ((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net)) nB9N2C20AO

BEIJING, Oct 20 (Reuters) - China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021, Chairman Liu Jingzhen said at a government press conference on Tuesday.

(Reporting by Roxanne Liu and Tony Munroe, editing by Louise Heavens)

((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More